Omvoh (mirikizumab-mrkz) for moderately to severely active Crohn’s disease in adults. Omvoh is now approved in the U.S. for ...
The study's primary goal is to assess the therapy’s tolerability, pharmacokinetics and safety in healthy volunteers.
Children who were diagnosed with inflammatory bowel disease (IBD) showed a decline in height, weight, and body mass index ...
Ulcerative colitis during pregnancy is manageable However timely detection and proper treatment are crucial to ensure a ...
Omvoh is now approved in the US for two types of inflammatory bowel disease (IBD), following its October 2023 approval as a first-in-class treatment for moderately to severely active ulcerative ...
CARLSBAD, CA - Palisade Bio, Inc. (NASDAQ: PALI), a clinical-stage biopharmaceutical company with a market capitalization of ...
Total Revenue Increases 5% Year-Over-Year - Achieves Sustained Revenue Growth, Improved Gross Margins, and Significant Cost Savings IRVINE, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: BMRA), ...
A woman who said she feared leaving her home for several weeks because she was so anxious about whether she would find a ...